Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension.

Cardiac magnetic resonance imaging Pulmonary arterial impedance Right heart catheterization Right ventricular-pulmonary arterial coupling

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2023
Historique:
revised: 30 08 2022
received: 07 07 2022
accepted: 15 09 2022
medline: 19 5 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

The effect of pulmonary hypertension (PH) on right ventricular (RV) afterload is commonly defined by elevation of pulmonary artery (PA) pressure or pulmonary vascular resistance (PVR). In humans however, one-third to half of the hydraulic power in the PA is contained in pulsatile components of flow. Pulmonary impedance (Zc) expresses opposition of the PA to pulsatile blood flow. We evaluate pulmonary Zc relationships according to PH classification using a cardiac magnetic resonance (CMR)/right heart catheterization (RHC) method. Prospective study of 70 clinically indicated patients referred for same-day CMR and RHC [60 ± 16 years; 77% females, 16 mPAP <25 mmHg (PVR <240 dynes.s.cm Baseline demographic characteristics were well matched. There was a significant difference in mPAP (P < 0.001), PVR (P = 0.001), and pulmonary Zc between mPAP<25 mmHg patients and those with PH (mPAP <25 mmHg: 47 ± 19 dynes.s.cm Raised pulmonary Zc was independent of elevated mPAP in patients with PH and more strongly predictive of maladaptive RV remodelling than PVR and mPAP. Use of this straightforward method to determine pulmonary Zc may help to better characterize pulsatile components of RV afterload in patients with PH than mPAP or PVR alone.

Sections du résumé

BACKGROUND
The effect of pulmonary hypertension (PH) on right ventricular (RV) afterload is commonly defined by elevation of pulmonary artery (PA) pressure or pulmonary vascular resistance (PVR). In humans however, one-third to half of the hydraulic power in the PA is contained in pulsatile components of flow. Pulmonary impedance (Zc) expresses opposition of the PA to pulsatile blood flow. We evaluate pulmonary Zc relationships according to PH classification using a cardiac magnetic resonance (CMR)/right heart catheterization (RHC) method.
METHODS
Prospective study of 70 clinically indicated patients referred for same-day CMR and RHC [60 ± 16 years; 77% females, 16 mPAP <25 mmHg (PVR <240 dynes.s.cm
RESULTS
Baseline demographic characteristics were well matched. There was a significant difference in mPAP (P < 0.001), PVR (P = 0.001), and pulmonary Zc between mPAP<25 mmHg patients and those with PH (mPAP <25 mmHg: 47 ± 19 dynes.s.cm
CONCLUSIONS
Raised pulmonary Zc was independent of elevated mPAP in patients with PH and more strongly predictive of maladaptive RV remodelling than PVR and mPAP. Use of this straightforward method to determine pulmonary Zc may help to better characterize pulsatile components of RV afterload in patients with PH than mPAP or PVR alone.

Identifiants

pubmed: 36896830
doi: 10.1002/ehf2.14180
pmc: PMC10192280
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1811-1821

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Chest. 2004 Jun;125(6):2121-8
pubmed: 15189931
Circ Res. 1969 Dec;25(6):637-49
pubmed: 5364641
JACC Cardiovasc Imaging. 2009 Mar;2(3):286-95
pubmed: 19356573
ESC Heart Fail. 2023 Jun;10(3):1811-1821
pubmed: 36896830
JAMA Cardiol. 2018 Apr 1;3(4):298-306
pubmed: 29541759
J Appl Physiol (1985). 2021 Jul 1;131(1):424-433
pubmed: 34043473
J Hypertens. 2016 Jun;34(6):1099-108
pubmed: 27054528
J Am Heart Assoc. 2018 Sep 18;7(18):e009459
pubmed: 30371198
Physiol Rev. 1982 Apr;62(2):570-623
pubmed: 6461866
J Am Coll Cardiol. 2011 Dec 6;58(24):2511-9
pubmed: 22133851
JACC Cardiovasc Imaging. 2016 Jun;9(6):715-32
pubmed: 27282439
Circ Res. 1984 Jun;54(6):666-73
pubmed: 6733863
J Physiol. 1969 May;202(1):10P
pubmed: 5770868
Physiol Rev. 1986 Jul;66(3):606-52
pubmed: 3526365
Monaldi Arch Chest Dis. 1995 Aug;50(4):282-5
pubmed: 7550208
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1731-7
pubmed: 16699074
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Eur Respir J. 2015 Jun;45(6):1603-12
pubmed: 25882798
Eur Respir J. 2002 Nov;20(5):1314-31
pubmed: 12449189
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1438-H1450
pubmed: 33035435
J Am Coll Cardiol. 1993 Feb;21(2):406-12
pubmed: 8426005
Circ Res. 1966 Sep;19(3):467-80
pubmed: 5925148
J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619
pubmed: 19389575
Cardiovasc Res. 1988 Sep;22(9):627-38
pubmed: 3242834
J Hypertens. 2021 Mar 1;39(3):437-446
pubmed: 33031178
Adv Physiol Educ. 2017 Sep 1;41(3):348-353
pubmed: 28679570
Cardiovasc Eng Technol. 2020 Jun;11(3):283-294
pubmed: 32314124

Auteurs

Sara Louise Hungerford (SL)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.
Department of Cardiology, Royal North Shore Hospital, Sydney, Australia.

Katherine Kearney (K)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

Ning Song (N)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

Nicole Bart (N)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

Eugene Kotlyar (E)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.

Edmund Lau (E)

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia.

Andrew Jabbour (A)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

Christopher Simon Hayward (CS)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

David William Marshall Muller (DWM)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.

Audrey Adji (A)

Department of Cardiology, St Vincent's Hospital, Darlinghurst, Australia.
The University of New South Wales, Sydney, Australia.
Victor Chang Cardiac Research Institute, Sydney, Australia.
BPVF department, Macquarie University Medical School, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH